Shannon Thyme Klinger is CLO at Moderna, Inc. (MRNA). They have made 26 open-market trades across 1 company since 2022, most recently 2026-09-04.
CIK 0001866132
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRNA | 81,340 | $21.0M |
| RFL | 5,412 | $6K |
| Total | $21.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRNA | SELL · 10b5-1 | 2026-09-01 | 2026-09-03 | $139.95 | $486K | -5.3% | +32.1% | — |
| MRNA | SELL · 10b5-1 | 2026-06-04 | 2026-06-08 | $50.00 | $174K | +34.6% | +55.4% | +195.2% |
| MRNA | SELL | 2026-03-02 | 2026-03-03 | $52.29 | $726K | -1.9% | -8.2% | -14.0% |
| MRNA | SELL | 2024-12-09 | 2024-12-10 | $44.68 | $24K | -6.0% | +0.8% | -14.2% |
| MRNA | SELL | 2024-12-03 | 2024-12-04 | $43.30 | $5K | -0.1% | +0.7% | -27.5% |
| MRNA | SELL | 2024-11-29 | 2024-12-02 | $42.79 | $121K | -2.6% | -4.5% | -31.2% |
| MRNA | SELL | 2024-09-09 | 2024-09-10 | $73.57 | $41K | -16.9% | -28.1% | -42.3% |
| MRNA | SELL | 2024-09-03 | 2024-09-04 | $76.99 | $9K | -5.0% | -17.3% | -41.5% |
| MRNA | SELL | 2024-08-29 | 2024-08-30 | $78.03 | $13K | -10.1% | -13.8% | -44.5% |
| MRNA | SELL | 2024-08-28 | 2024-08-29 | $79.39 | $209K | +1.3% | -14.8% | -44.7% |
| MRNA | SELL | 2024-06-10 | 2024-06-11 | $148.09 | $1.5M | -8.7% | -18.1% | -48.9% |
| MRNA | SELL | 2024-06-03 | 2024-06-04 | $140.72 | $17K | -4.6% | -19.4% | -50.3% |
| MRNA | SELL | 2024-05-29 | 2024-05-30 | $144.50 | $26K | -2.4% | -23.8% | -48.5% |
| MRNA | SELL | 2024-05-28 | 2024-05-29 | $162.47 | $421K | -1.2% | -21.0% | -47.5% |
| MRNA | SELL | 2024-03-08 | 2024-03-11 | $99.05 | $108K | -7.1% | -4.3% | +32.7% |
| MRNA | SELL | 2024-03-04 | 2024-03-05 | $94.34 | $11K | +7.8% | +6.1% | +53.4% |
| MRNA | SELL | 2024-02-29 | 2024-03-01 | $94.57 | $127K | +12.5% | +11.6% | +60.1% |
| MRNA | SELL | 2023-12-08 | 2023-12-11 | $79.09 | $45K | +12.2% | +34.7% | +37.8% |
| MRNA | SELL | 2023-12-04 | 2023-12-05 | $79.31 | $9K | +8.9% | +37.6% | +21.6% |
| MRNA | SELL | 2023-09-08 | 2023-09-11 | $107.22 | $119K | -4.9% | -2.5% | -22.2% |
| MRNA | SELL | 2023-09-05 | 2023-09-06 | $111.44 | $13K | -3.2% | -3.5% | -27.3% |
| MRNA | SELL | 2023-06-08 | 2023-06-09 | $124.09 | $140K | -2.3% | -0.2% | -12.2% |
| MRNA | SELL | 2023-06-02 | 2023-06-05 | $130.32 | $14K | +0.8% | -4.2% | -15.2% |
| MRNA | SELL | 2023-03-08 | 2023-03-09 | $141.51 | $159K | +11.0% | +16.8% | -8.4% |
| MRNA | SELL | 2023-03-02 | 2023-03-03 | $136.43 | $125K | +4.4% | +11.3% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.